Patents Assigned to Natura Corporation
  • Method for inhibiting onset of or treating pollen allergy
    Patent number: 8802641
    Abstract: The intermolecular mutual recognition between a disease-state inducing substance (e.g., allergen group, pathogen et cetera) and a living body which functions at the time when such a disease-state inducing substance reaches the living body is inhibited by making use of pectins and nucleic acids.
    Type: Grant
    Filed: April 13, 2009
    Date of Patent: August 12, 2014
    Assignee: Natura Corporation
    Inventors: Masafumi Koide, Ryutaro Tsuda, Kenji Fujisawa